Abstract
Chronic kidney disease (CKD) is prevalent among people with diabetes. Many people with CKD suffer from anemia as a complication. Despite its prevalence in CKD, anemia tends to be an underrecognized and undertreated condition in this population. Since the 1980s, effective treatments to correct anemia have been available. Additionally, newer treatments are on the horizon that have the potential to provide additional therapy options to improve outcomes for patients with anemia in CKD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Clinical diabetes : a publication of the American Diabetes Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.